These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 2848683)

  • 21. Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor.
    Nissenson RA; Strewler GJ; Williams RD; Leung SC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5358-63. PubMed ID: 2996759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human PTH-(3-34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells).
    Nakai M; Fukase M; Yamaguchi T; Tsukamoto T; Fujii N; Fujita T
    J Bone Miner Res; 1990 Oct; 5(10):995-1002. PubMed ID: 1964359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
    Titus L; Jackson E; Nanes MS; Rubin JE; Catherwood BD
    J Bone Miner Res; 1991 Jun; 6(6):631-7. PubMed ID: 1653516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J; Bernier S; D'Amour P; Goltzman D
    Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta enhances parathyroid hormone stimulation of adenylate cyclase in clonal osteoblast-like cells.
    Gutierrez GE; Mundy GR; Manning DR; Hewlett EL; Katz MS
    J Cell Physiol; 1990 Sep; 144(3):438-47. PubMed ID: 2391378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
    Blind E; Raue F; Knappe V; Schroth J; Ziegler R
    Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein.
    Fukayama S; Tashjian AH
    Endocrinology; 1989 Jan; 124(1):397-401. PubMed ID: 2909373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone (PTH)/PTH-related protein receptor messenger ribonucleic acid expression and PTH response in a rat model of secondary hyperparathyroidism associated with vitamin D deficiency.
    Turner G; Coureau C; Rabin MR; Escoubet B; Hruby M; Walrant O; Silve C
    Endocrinology; 1995 Sep; 136(9):3751-8. PubMed ID: 7649081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic human parathyroid hormone-related protein and rat renal electrolyte transport.
    Carney SL; Ray C; Ebeling PR; Martin TJ; Gillies AH
    Miner Electrolyte Metab; 1991; 17(1):41-5. PubMed ID: 1663207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of a gene encoding parathyroid hormone-like protein-(1-141): purification and biological characterization of the expressed protein.
    Thorikay M; Kramer S; Reynolds FH; Sorvillo JM; Doescher L; Wu T; Morris CA; Burtis WJ; Insogna KL; Valenzuela DM
    Endocrinology; 1989 Jan; 124(1):111-8. PubMed ID: 2535801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34.
    Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR
    J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2.
    Whitfield JF; Morley P; Willick GE; Isaacs RJ; MacLean S; Ross V; Barbier JR; Divieti P; Bringhurst FR
    J Bone Miner Res; 2000 May; 15(5):964-70. PubMed ID: 10804028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthetic human parathyroid hormone-related protein is inhibited by a parathyroid hormone antagonist in rats in vivo.
    Horiuchi N; Hongo T; Clemens TL
    J Bone Miner Res; 1990 Jun; 5(6):541-5. PubMed ID: 2166420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-1 parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH(1-34).
    Takasu H; Bringhurst FR
    Endocrinology; 1998 Oct; 139(10):4293-9. PubMed ID: 9751512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
    Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
    Burtis WJ; Broadus AE; Insogna KL; Weir EC; Stewart AF
    Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C modulates parathyroid hormone- but not prostaglandin E2-mediated stimulation of cyclic AMP production via the inhibitory guanine nucleotide binding protein in UMR-106 osteosarcoma cells.
    Koch HM; Muir H; Gelderblom D; Hough S
    J Bone Miner Res; 1992 Dec; 7(12):1353-62. PubMed ID: 1336300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of extended and deleted recombinant analogues of parathyroid hormone-(1-84): correlation of peptide structure with function.
    Rabbani SA; Kaiser SM; Henderson JE; Bernier SM; Mouland AJ; Roy DR; Zahab DM; Sung WL; Goltzman D; Hendy GN
    Biochemistry; 1990 Oct; 29(43):10080-9. PubMed ID: 2176861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.